The following is a summary of the ISpecimen Inc. (ISPC) Q1 2024 Earnings Call Transcript:

Financial Performance:

• iSpecimen reported Q1 2024 revenue of approximately $2.3 million, a decrease from approximately $3 million for the same quarter in the previous year.

• Cost of revenue decreased by approximately $147,000 or 13% from the same period last year.

• Technology expenses increased by approximately $78,000 or 9% while sales and marketing expenses decreased by about $296,000 or 31%.

• General and administrative expenses increased by approximately $286,000 or 16% from the same quarter in 2023.

Business Progress:

• iSpecimen initiated several organizational changes including reducing compensation costs by 41% and technology expenses by 66% from Q1 2023.

• Significant developments have been made to the Next-Day Quotes Program, with its prospective purchase order dollar value increasing by 190% in Q1 2024.

• The company reduced its supplier network to enhance specimen quality and availability, and is focused on increasing revenues through the Next-Day Quotes Program and revenue enhancement projects.

More details: iSpecimen IR

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.